NFKB1 and neoplasm: The NF-κB inhibitors Bay 11-7082 [91] and dehydroxymethylpoxyquinomycin (DHMEQ) [92,93,94,95] inhibit tumor formation and invasion derived from HTLV-1-infected cell lines implanted in severely immunodeficient mice.